Tag: narrow therapeutic index

Prescribers remain divided on generic substitution for narrow therapeutic index (NTI) drugs like warfarin, lithium, and tacrolimus. Despite FDA assurances, many doctors prefer brand-name versions due to stability concerns, inconsistent communication, and state-level restrictions.